Study on the Risk of Allergy-like Reactions After Intra-arterial or Intra-venous Injection of the Marketed X-ray Contrast Medium Iopromid
Clinical trial NCT03622801 · COMPLETED
Trial details
- NCT number
- NCT03622801
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-12
- Primary completion
- 2019-02-14
- Enrollment
- 133331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.